RemeGen , Ltd. Profit Margin

The latest profit margin for REGMF is 72.71% as of June 2026. That compares with -54.87% in the prior-year period — up 232.5% year over year. That is above the Healthcare sector average of 10.58%. Investors often review this figure alongside RemeGen , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, REGMF's profit margin moved from -54.87% to 72.71% — a 232.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RemeGen , Ltd.'s valuation or profitability profile.

Against Healthcare companies, REGMF currently prints 72.71% for profit margin, while the sector average sits near 10.58%. That is roughly 587.2% above the sector mean. Large gaps often invite a closer look at RemeGen , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively RemeGen , Ltd. converts resources into returns. At 72.71%, REGMF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -54.87% in the prior-year period — up 232.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting REGMF's profit margin (72.71%), review year-over-year change from -54.87%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.